SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors weigh strong profitability and massive cash reserves against stagnant revenue and the absence of a clear acquisition roadmap. The community is sharply divided, with bulls pointing to the company's solid balance sheet while vocal detractors criticize the CEO's compensation proposals and the lack of an earnings call.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as investors grapple with conflicting reports regarding US-Iran ceasefire negotiations, driving intense debate over the reliability of recent market pumps. Sentiment is sharply divided between bulls focused on the potential of the Terafab chip project and the rumored SpaceX merger, and vocal bears who argue the stock remains fundamentally overvalued and relies on speculative promises.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors weigh its aggressive mortgage product expansion and AI-integrated operations against intense macroeconomic headwinds and geopolitical volatility. The community remains deeply polarized, with bulls championing the company's turnaround potential and efficiency gains, while vocal short-sellers focus on price action and institutional selling pressures.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing intense volatility as investors speculate on upcoming NASA contract awards, specifically the Lunar Terrain Vehicle (LTV) program, while reacting to new revenue guidance and expanded infrastructure goals. The community remains deeply divided, with bulls pointing to growing backlogs and strategic partnerships as long-term validation, while bears argue the stock's price movements are driven more by hype and speculative retail trading than confirmed financial performance.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its organic, 'bongterm' growth model, often comparing its long-term potential to a cultural movement rather than a typical meme coin. The discussion is heavily focused on the project's upcoming one-year anniversary and the anticipation surrounding 4/20, with supporters highlighting its role as a global cannabis culture currency on Solana.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant volatility as investors weigh the competitive threat of Costco's new private-label energy drink against the company's strong brand loyalty and global growth potential. The community remains deeply divided, with bulls viewing the stock's recent pullback as a buying opportunity based on long-term fundamentals, while bears and skeptics argue that increased competition and management concerns create an uncertain outlook.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending as investors react to on-chain evidence verifying its utility in global payroll and institutional settlement, while the community intensely debates its long-term potential compared to other major assets. Sentiment remains polarized, with many users focused on accumulation strategies amid broader market volatility and speculation surrounding institutional adoption.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is seeing intense volatility and retail-driven momentum as investors speculate on its exposure to high-profile AI companies like Anthropic, SpaceX, and OpenAI. While the community is actively debating the stock's massive premium over its reported net asset value (NAV) and the impact of a six-month lockup on shares, many are comparing its current parabolic run to other low-float, high-hype market phenomena.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is experiencing a significant surge in momentum following highly positive Phase 1 clinical trial results for its CML drug, TERN-701, which has drawn extensive interest from analysts and institutional investors. While the community is actively debating the stock's elevated valuation and potential for a future acquisition, many traders remain focused on the company's financial runway and the ongoing speculation regarding possible equity offerings to fund further development.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is trending as retail investors rally behind the stock, viewing recent downward pressure as a manipulative "short attack" rather than a reflection of fundamental weakness. The community is actively debating the credibility of the short report, calling for management to issue a public rebuttal while many express strong conviction in the companys share buyback program and long-term trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Message from Our Chief Executive Officer

Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal year 2026, covering the six-month...

<ul class="summary-bullets"><li>Moolec cultivated about 1,100 acres of engineered safflower across the United States during the 2025 season.</li><li>Average yields were around 2,200 pounds per acre, exceeding the company’s expectations.</li><li>Moolec confirmed that the Nasdaq Stock Market Hearings Panel approved its request for continued listing on January 30.</li></ul>Shares of Moolec Science S.A. (MLEC) soared more than 130% on Friday after the company announced strong results from the crushing phase of its U.S. GLASO safflower platform, confirming gamma-linolenic acid (GLA) concentrations of around 45%.The milestone follows the successful completion of the company’s 2025 safflower campaign and validates its plant-engineered molecular farming technology for commercial-scale agricultural and industrial production, Moolec said.<h2 class="st-heading-2">Moolec’s Crushing Results Validate Scalability</h2>After harvest, the engineered safflower was processed through standard U.S. crushing facilities with results confirming that the GLASO platform can perform reliably at scale.Moolec cultivated about 1,100 acres of engineered safflower across the United States during the 2025 season. Average yields were around 2,200 pounds per acre, up from around 1,400 pounds in 2024, exceeding the company’s internal expectations.“Achieving approximately 45% GLA concentration at commercial scale confirms that our technology is not only scientifically differentiated, but operationally executable within existing U.S. agricultural and processing infrastructure. Our focus now is to build on this foundation through disciplined growth and the conversion of this operational advantage into sustainable, recurring revenue,” said Alejandro Antalich, CEO at Moolec Science.On January 30, Moolec confirmed that the Nasdaq Stock Market Hearings Panel approved its request for continued listing after the company regained compliance with the minimum bid price requirements following a one-for-15 reverse share split, which took effect earlier in the month.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, accompanied by ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/MLEC_jpg_62c7e429b6.webp" alt="MLEC.jpg">One user expects <a href="https://stocktwits.com/symbol/MLEC">MLEC shares</a> to climb to $20. It is currently trading at $11.4.<stembedurl>https://stocktwits.com/widar/message/644938608</stembedurl>Year-to-date, the stock has gained 241%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cnvs-stock-rallies-on-indicue-acquisition/cZR5xVUR4tc">CNVS Stock Surged 20% Today, Breaching 100-DMA For First Time Since August – Here’s What Triggered The Rally</a> For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did This Nano-Cap Food Stock More Than Double In Value Today?

The company announced positive crushing results from its U.S. GLASO safflower platform, confirming GLA concentrations of about 45%.

Equity

Bioceres Crop Solutions (BIOX) Projected to Post Quarterly Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) will be releasing its Q2 2026 earnings before the market opens on Tuesday, February 10. (View Earnings Report at...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Down 25.4% in January

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 15th, there was short interest...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Large Decline in Short Interest

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 31st, there was short interest...

Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $2.00 by Analysts at Canaccord Genuity Group

Canaccord Genuity Group decreased their price objective on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a "hold" rating on the stock in a research note on Friday...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Rating of "Hold" by Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has received an average recommendation of "Hold" from the five research firms that are covering the company, Marketbeat Ratings reports...

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of "Hold" from Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) have been given a consensus recommendation of "Hold" by the five analysts that are presently covering the stock, Marketbeat...

Bioceres Crop Solutions (NASDAQ:BIOX) Upgraded by Wall Street Zen to "Hold" Rating

Wall Street Zen raised shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a report on Saturday...

Bioceres Crop Solutions (NASDAQ:BIOX) Price Target Cut to $2.25 by Analysts at Canaccord Genuity Group

Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $2.50 to $2.25 and set a "hold" rating on the stock in a research report on Friday...

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.05	--	--	N/A
Q2 '26	$0.07	--	--	N/A
Q1 '26	-$0.08	-$0.12	-52.64%	MISSED
Q4 '25	$0.07	-$0.70	-1138.44%	MISSED
Q3 '25	-$0.12	-$0.02	83.44%	BEAT

BIOX
Bioceres Crop Solutions Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '26

Historical Earnings

Latest BIOX News

BIOXBioceres Crop Solutions Corp